Preoperative Identification of Benefit from Surgery for Malignant Pleural Mesothelioma.

Humans Mesothelioma, Malignant / diagnosis Patient Selection Pleural Neoplasms / diagnosis Preoperative Care Prognosis
Malignant pleural mesothelioma Prognostic factors Surgery Survival

Journal

Thoracic surgery clinics
ISSN: 1558-5069
Titre abrégé: Thorac Surg Clin
Pays: United States
ID NLM: 101198195

Informations de publication

Date de publication:
Nov 2020
Historique:
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 9 2 2021
Statut: ppublish

Résumé

In the absence of standardized treatment algorithms for patients with malignant pleural mesothelioma, one of the main difficulties remains patient allocation to therapies with potential benefit. This article discusses clinical, radiologic, pathologic, and molecular prognostic factors as well as genetic background leading to preoperative identification of benefit from surgery, which have been investigated over the past years to simplify and at the same time specify patient selection for surgical treatment.

Identifiants

DOI: 10.1016/j.thorsurg.2020.08.003 PMID: 33012431
pubmed: 33012431
pii: S1547-4127(20)30065-7
doi: 10.1016/j.thorsurg.2020.08.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-449

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have nothing to disclose.

Auteurs

Isabelle Opitz (I)

Department of Thoracic Surgery, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland. Electronic address: Isabelle.schmitt-opitz@usz.ch.

Katarzyna Furrer (K)

Department of Thoracic Surgery, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Preoperative Identification of Benefit from...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs de la plèvre › Mésothéliome malin › Preoperative Identification of Benefit from...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Sélection de patients › Preoperative Identification of Benefit from...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs de la plèvre › Preoperative Identification of Benefit from...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Soins aux patients › Soins périopératoires › Soins préopératoires › Preoperative Identification of Benefit from...
questionsmedicales.fr › Diagnostic › Pronostic › Preoperative Identification of Benefit from...